中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共3条，第1-3条 帮助

已选(0)清除 条数/页：   排序方式：
Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial 期刊论文
BMC MEDICINE, 2022, 卷号: 20
作者:  Song, Zhengbo;  Lou, Guangyuan;  Wang, Yina;  Yang, Zhiping;  Wang, Wenxian;  Ji, Yongling;  Chen, Shiqing;  Xu, Chunwei;  Hu, Xiao;  Zhang, Yiping
收藏  |  浏览/下载：22/0  |  提交时间：2022/12/23
Thymic epithelial tumors  Apatinib  Efficacy  Toxicities  
Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes 期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 卷号: 9
作者:  Chen, Xiaofeng;  Wang, Deqiang;  Liu, Jing;  Qiu, Jingrong;  Zhou, Jun;  Ying, Jieer;  Shi, Yan;  Wang, Zhaoxia;  Lou, Haizhou;  Cui, Jiuwei;  Zhang, Jingdong;  Liu, Yunpeng;  Zhao, Fengjiao;  Pan, Lanlan;  Zhao, Jianyi;  Zhu, Dongqin;  Chen, Shiqing;  Li, Xiangcheng;  Li, Xue;  Zhu, Liuqing;  Shao, Yang;  Shu, Yongqian
收藏  |  浏览/下载：50/0  |  提交时间：2022/01/10
immunotherapy  tumor microenvironment  biomarkers  tumor  genetic markers  
Efficacy and Resistance of Afatinib in Chinese Non-Small Cell Lung Cancer Patients With HER2 Alterations: A Multicenter Retrospective Study 期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 11
作者:  Song, Zhengbo;  Lv, Dongqing;  Chen, Shiqing;  Huang, Jianhui;  Wang, Liping;  Xu, Shuguang;  Chen, Huafei;  Wang, Guoqiang;  Lin, Quan
收藏  |  浏览/下载：55/0  |  提交时间：2021/06/21
non-small cell lung cancer (NSCLC)  HER2  afatinib  efficacy  resistance